Estudo Cl?nico da Otite em Felinos e a Efic?cia in vitro e in vivo da Levofloxacina no tratamento t?pico da otite externa

• Main Author: Laguna, Ana?s Gabriela Villarreal
• Publication Date: 2015
• Format: Master thesis
• Language: por
• Source: Biblioteca Digital de Teses e Dissertações da UFRRJ
• Download full: https://tede.ufrrj.br/jspui/handle/jspui/1436
• topic: external otitis; bacterial otitis; levofloxacin; cats; otite externa,, ,; otite bacteriana; Levofloxacina; gatos; Medicina Veterin?ria

Otitis is defined as an inflammation, acute or chronic, of the ear canal and it?s considered one of the most common diseases in small animal practice. It possesses various perpetuating agents, bacteria and yeast being the most common. Treatment is based in the recognition of the primary causes and predisposing factors, and the resolution of secondary infections. A greater sensitivity in feline ear canal has also been shown, when compared to dogs. With this in mind, a product with the least possible active ingredients would be the ideal topical treatment in felines. However, the majority of available products combine antibiotics and antifungals, this combination not being necessary in all cases; for bacterial otitis, very few specific products exist, and some of them present a proven ototoxic potential. In face of this problem, the efficacy of a new formulation using levofloxacin for the specific treatment of bacterial otitis was made by the Farmacologia e Farmacometria sector of the LQEPV ? UFRRJ, using isopropylic alcohol as vehicle. Eighteen adult felines, belonging to the Laborat?rio de Quimioterapia Experimental em Parasitologia Veterin?ria (LQEPV-UFRRJ), diagnosed with bacterial otitis according to clinical signs (erythema, inflammation, pruritus, hyperpigmentation and secretions), as well as cytological exams and video-otoscopy, were chosen. Individual data was registered in specific formularies for comparison of pretreatment and post treatments evaluations. After the initial evaluation the animals were divided into three groups, according to treatment: in Group A or control (6 animals) a placebo (vehicle) was used; in Group B (6 animals) a formulation of levofloxacin 0, 5% was used; Group C (6 animals) a formulation of de levofloxacin 0, 5% + dexamethasone 0, 02% was used. In every case 0, 5 ml was applied to each ear, once a day for 15 consecutive days. Post treatment video-otoscopies were performed on day +21, and post treatment cytologies were performed on days +7, +14 and +21. The animals were always observed by the same evaluator, avoiding errors of concordance and checking for possible reactions to the product. None of the animals presented adverse reactions to the product during the treatment period, besides slight discomfort immediately after application. Animals from Group A continued with the same scores until the end of the experiment. Animals from Group B presented an initial clinical improvement, but some of them developed a fungal otitis as time passed. Animals from Group C presented a significant improvement since day +7, with no secondary alterations through time. It is demonstrated that a formulation of de levofloxacin + dexamethasone can be efficient and safe for the treatment of feline bacterial otitis